Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;7(Suppl 8):S276.
doi: 10.21037/atm.2019.12.13.

Is there a role for immunotherapy in ovarian cancer?

Gaia Giannone  1   2 , Giorgio Valabrega  1   2
Affiliations
Editorial

Is there a role for immunotherapy in ovarian cancer?

Gaia Giannone et al. Ann Transl Med. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: G Valabrega has received personal fees from Roche, AstraZeneca, Tesaro, PharmaMar, Amgen. G Giannone has no conflicts of interest to declare.

Comment on

References

    1. Available online: https://seer.cancer.gov/statfacts/html/ovary.html, 2019.
    1. Colombo N, Sessa C, du Bois A, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol 2019;30:672-705. 10.1093/annonc/mdz062 - DOI - PubMed
    1. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;348:203-13. 10.1056/NEJMoa020177 - DOI - PubMed
    1. Hwang WT, Adams SF, Tahirovic E, et al. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol 2012;124:192-8. 10.1016/j.ygyno.2011.09.039 - DOI - PMC - PubMed
    1. Strickland KC, Howitt BE, Shukla SA, et al. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer. Oncotarget 2016;7:13587-98. 10.18632/oncotarget.7277 - DOI - PMC - PubMed